Carnegie Investment Counsel Sells 676 Shares of Mettler-Toledo International, Inc. $MTD

Key Points

• Carnegie Investment Counsel reduced its stake in Mettler-Toledo International by 5.3%, selling 676 shares and owning a total of 12,065 shares worth approximately $14.2 million.
• Several analysts have raised their price targets for Mettler-Toledo, with Citigroup increasing its target from $1,400 to $1,600 and Barclays from $1,325 to $1,350.
• Insider transactions revealed substantial sales, including director Thomas P. Salice selling 1,062 shares for over $1.3 million, indicating a significant decrease in his ownership by nearly 79%.

Carnegie Investment Counsel lowered its position in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 5.3% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 12,065 shares of the medical instruments supplier's stock after selling 676 shares during the quarter. Carnegie Investment Counsel owned about 0.06% of Mettler-Toledo International worth $14,173,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. Greenleaf Trust boosted its position in shares of Mettler-Toledo International by 1.2% during the 1st quarter. Greenleaf Trust now owns 872 shares of the medical instruments supplier's stock worth $1,030,000 after purchasing an additional 10 shares in the last quarter. Brooklyn Investment Group boosted its position in shares of Mettler-Toledo International by 12.8% during the 1st quarter. Brooklyn Investment Group now owns 88 shares of the medical instruments supplier's stock worth $104,000 after purchasing an additional 10 shares in the last quarter. Sax Wealth Advisors LLC raised its holdings in shares of Mettler-Toledo International by 2.8% in the 2nd quarter. Sax Wealth Advisors LLC now owns 372 shares of the medical instruments supplier's stock worth $437,000 after acquiring an additional 10 shares during the last quarter. Albion Financial Group UT raised its holdings in shares of Mettler-Toledo International by 1.5% in the 1st quarter. Albion Financial Group UT now owns 754 shares of the medical instruments supplier's stock worth $890,000 after acquiring an additional 11 shares during the last quarter. Finally, Sequoia Financial Advisors LLC raised its holdings in shares of Mettler-Toledo International by 1.8% in the 1st quarter. Sequoia Financial Advisors LLC now owns 627 shares of the medical instruments supplier's stock worth $740,000 after acquiring an additional 11 shares during the last quarter. Institutional investors own 95.07% of the company's stock.

Analysts Set New Price Targets

MTD has been the topic of a number of analyst reports. Robert W. Baird upped their target price on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a "neutral" rating in a report on Monday, August 4th. Weiss Ratings restated a "hold (c)" rating on shares of Mettler-Toledo International in a report on Wednesday, October 8th. Citigroup upped their target price on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a "buy" rating in a report on Thursday, August 21st. JPMorgan Chase & Co. upped their target price on shares of Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the stock a "neutral" rating in a report on Thursday, October 9th. Finally, Barclays upped their target price on shares of Mettler-Toledo International from $1,325.00 to $1,350.00 and gave the stock an "overweight" rating in a report on Thursday, October 2nd. Five equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $1,336.50.

Insider Transactions at Mettler-Toledo International

In other news, insider Gerry Keller sold 165 shares of the firm's stock in a transaction that occurred on Thursday, August 14th. The shares were sold at an average price of $1,308.64, for a total transaction of $215,925.60. Following the completion of the sale, the insider owned 94 shares in the company, valued at $123,012.16. This trade represents a 63.71% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Thomas P. Salice sold 1,062 shares of the firm's stock in a transaction that occurred on Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the completion of the transaction, the director directly owned 283 shares of the company's stock, valued at approximately $368,154.70. This trade represents a 78.96% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 1,827 shares of company stock worth $2,371,208 in the last quarter. Insiders own 1.94% of the company's stock.

Mettler-Toledo International Stock Up 4.0%

Shares of MTD stock opened at $1,436.21 on Friday. The company has a 50 day moving average of $1,294.84 and a 200-day moving average of $1,203.48. Mettler-Toledo International, Inc. has a 12-month low of $946.69 and a 12-month high of $1,438.70. The firm has a market cap of $29.58 billion, a P/E ratio of 36.37, a PEG ratio of 4.15 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.58 by $0.51. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The company had revenue of $983.22 million during the quarter, compared to analyst estimates of $957.41 million. During the same quarter last year, the business posted $9.65 EPS. Mettler-Toledo International's quarterly revenue was up 3.9% compared to the same quarter last year. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. As a group, equities analysts expect that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.